We characterized six self-indicating substrates, synthesized as the derivative compounds of acetyiphenyl phosphate, for serum prostatic acid phosphatase (PAP) activity. One of the substrates, 2,6-dichloro-4-acetylphenyl phosphate (DCAPP), is superior to others in terms of stability, affinity, and low Km for PAP. The hydrolyzed product, 2,6-dichloro-4-acetylphenol (DCAP), has a maximum absorption at 334.2 nm, a PKa of 4.15, and a molar absorptivity at 340 nm of 21 490 L-mor1 cm1 in citrate-HCI buffer, pH 5.4. PAP activity was assessed by subtracting tartaric acid-inhibited acid phosphatase activity from total acid phosphatase activity. Our assay system involving DCAPP is a unique kinetic method that shows good reproducibility, wide analytical dynamic range, and high specificity for PAP. Moreover, it is easily adaptable to automated analyzers because the product, DCAP, can be monitored at 340 nm. 
Materials and Methods

Apparatus
Spectra of substrates and their products were analyzed with a Hitachi U-3200 spectrophotometer (Hitachi, Tokyo, Japan) and enzyme activity 
Samples
PAP in serum was stabilized by adding 10 L of 3.3 mol/L acetic acid per 1.0 mL of serum immediately after serum was separated from clotted blood. Pretreated sera were stored at -20#{176}C until use. 
PAP Assay
In experiments comparing substrates, we pipetted 100 .iL of sample, mixed it with 2 mL of buffer solution, incubated the mixture for 3 mm to reach 37#{176}C, and started monitoring the reaction rate at 340 nm immediately after adding 500 .iL of substrate solution. The final pH of the mixture was 5.4. We used the Hitachi 7050 automated analyzer in other experiments, mixing 20 pi of sample with 400 L of buffer solution and then adding 100 p.L of substrate solution to start the reaction. We monitored the reaction in rate mode from 140 to 240 s at 340 nm and calculated the enzyme activity from #{163}4lmin. We estimated the PAP activity by subtracting TIAP activity from T-ACP activity; we investigated the inhibitory effects of L-tartaric acid on PAP activity in crude extract from various organs. Km was calculated by a Lineweaver-Burk plot. To obtain the Km of ACP from various organs, we used eight concentrations of DCAPP between 0.01 and 0.5 mmol/L and measured each point three times.
Characterization of Substrates and Their Products
The apparent s was determined
by using the Hitachi U-3200 spectrophotometer and a Hitachi automated analyzer.
Interferences
Besides examining interferences of various compounds with PAP activity, we also investigated the effects of various abnormal sera on the spectrophotometry itself, not on the enzyme activity. The sera tested were hemolytic (n = 10; maximum concentration 1000 mg/L as hemoglobin), icteric (n = 13; maximum concentration 20 mg/L as total bilirubin), and lipemic (n = 5; turbid appearance).
In this experiment we omitted substrate from reagent 2.
Comparison of Methods
To compare the present method (applied to automated analyzers) with the DCNPP method, the 1-NA method, and the PAP EIA method, we used several stabilized human sera. The enzymatic methods were run on the Hitachi 7050 analyzer and the PAP EIA method on the IB-500 analyzer according to each manufacturer's instructions. 
Evaluation of the Present Method by Automated Analyzers
Molar absorptivity (e). As described above, the apparent e for DCAP was determined to be 21 490 L -mol' -cm1 at 340 nm on the Hitachi U-3200 spectrophotometer.
With the Hitachi 7050 automated analyzer, s was 19 950 L-mo11 cm at 340 nm, and the calculated K-factor was 1295.
Analytical range.
The detection limit of the PAP assay was calculated according to Miller and Miller (12) . The mean value obtained from 30 measurements of a blank (isotonic saline) was 0.83 nkat/L (SD 1.7 nkat/L), and the detection limit was 5.0 nkat/L. The upper limit of linearity with PAP was 2167 nkatlL at 37#{176}C.
Precision. The recovery was between 103% and 104%.
Interferences.
Substances tested did not interfere with measured PAP activity. Spectrophotometrically, the interfering effects of abnormal sera tested were negligible at those concentrations (Table 2) . mol/L when using DCAPP as the substrate.
Since the Km of PAP was 0.1 that of ACP from blood cells, the affinity of DCAPP for PAP turned out to be stronger than for ACP from blood cells (Table 1) .
We selected 1.15 X 10 mol/L as the final substrate concentration at which the V, was 89% with PAP. For PAP activity measurement, the substrate concentration should be >1.15 x i0 mol/L, but this will result in high blank value (>0.1 A), as shown in Fig. 1 .
In this study, we measured PAP activity by L-tartrate inhibition.
The PAP activity was inhibited by 98% with 20 mmolIL L-tartrate, whereas ACP from blood cells was inhibited by 0.6-20.1%. The inhibition rate of PAP in this study was in good agreement with that of the 1-NA method, whereas that of ACP from other organs was not (3). 
